A REVIEW OF ARTIFICIAL INTELLIGENCE IN TREATMENT OF COVID-19

Abstract

Drug repurposing, also known as repositioning, is a technique in which existing drugs are repurposed to treat emerging and complex diseases like COVID-19. Because of the potential for shorter development timelines and lower overall costs, drug repurposing has emerged as a promising strategy. In the significant data era, artificial intelligence (AI) and network medicine provide cutting-edge information science applications to define disease, medicine, therapeutics, and identify targets with the smallest error. We present guidelines for using AI to accelerate drug repurposing or repositioning, for which AI approaches are formidable and required in this Review. We discuss how to use AI models in precision medicine, such as how AI models can accelerate COVID-19 drug repurposing. Rapidly developing, powerful, and innovative AI and network medicine technologies can help to accelerate therapeutic development. This Review makes a strong case for using artificial intelligence-powered assistive tools to repurpose medications for human disease, including during the COVID-19 pandemic.